文献速递冠心病外科

微创冠脉搭桥与PCI治疗左前降支复杂狭窄的对比

Minimally invasive coronary bypass versus percutaneous coronary intervention for isolated complex stenosis of the left anterior descending coronary artery.
PubMed 文献 · J Thorac Cardiovasc Surg · 2020-05-29

本研究回顾性分析2008至2016年间接受血运重建的孤立性左前降支复杂病变患者,经倾向性匹配形成158对,比较微创冠脉搭桥与二代药物洗脱支架PCI的中期结局。结果显示两组9年生存率无显著差异,但搭桥组再次左前降支干预需求显著更低,PCI组高龄和肥胖预测晚期死亡增加。

要点

  • 孤立性左前降支复杂病变中,微创搭桥与PCI的9年生存率无显著差异。
  • 微创搭桥组再次左前降支血运重建需求显著低于PCI组。
  • PCI组中高龄和肥胖与晚期死亡风险增加相关。

核心结论

  • 对于左前降支复杂病变,微创搭桥与PCI均与良好的中期生存相关,但搭桥后再次干预需求更低。

研究设计与样本

  • 回顾性分析2008年1月至2016年12月接受冠脉血运重建的患者,经倾向性匹配形成158对,比较微创搭桥与二代药物洗脱支架PCI。

主要发现

  • 倾向性匹配前后,两组9年总生存率均无显著差异。
  • 匹配后微创搭桥组中期死亡率低,且不随患者风险特征变化。
  • 倾向性匹配前后,微创搭桥组再次左前降支血运重建的可能性均显著低于PCI组。

临床怎么用

  • 在左前降支复杂病变选择血运重建方式时,需权衡再次干预风险与PCI的晚期死亡预测因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Debate continues as to the optimal minimally invasive treatment modality for complex disease of the left anterior descending coronary artery, with advocates for both robotic-assisted minimally invasive direct coronary artery bypass and percutaneous coronary intervention with a drug-eluting stent. We analyzed the midterm outcomes of patients with isolated left anterior descending disease, revascularized by minimally invasive direct coronary artery bypass or drug-eluting stent percutaneous coronary intervention, focusing on those with complex lesion anatomy. METHODS: A retrospective review was undertaken of all patients who underwent coronary revascularization between January 2008 and December 2016. From this population, 158 propensity-matched pairs of patients were generated from 158 individuals who underwent minimally invasive direct coronary artery bypass for isolated complex left anterior descending disease and from 373 patients who underwent percutaneous coronary intervention using a second-generation drug-eluting stent. Midterm survival and incidence of repeat left anterior descending intervention were analyzed for both patient groups. RESULTS: Overall 9-year survival was not significantly different between patient groups both before and after propensity matching. Midterm mortality in the matched minimally invasive direct coronary artery bypass group was low, irrespective of patient risk profile. By contrast, advanced age (hazard ratio, 1.10; P = .012) and obesity (hazard ratio, 1.09; P = .044) predicted increased late death after drug-eluting stent percutaneous coronary intervention among matched patients. Patients who underwent minimally invasive direct coronary artery bypass were significantly less likely to require repeat left anterior descending revascularization than those who had percutaneous coronary intervention, both before and after propensity matching. Smaller stent diameter in drug-eluting stent percutaneous coronary intervention was associated with increased left anterior descending reintervention (hazard ratio, 3.53; P = .005). CONCLUSIONS: In patients with complex disease of the left anterior descending artery, both minimally invasive direct coronary artery bypass and percutaneous coronary intervention are associated with similar excellent intermediate-term survival, although reintervention requirements are lower after surgery.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Patel NC, Hemli JM, Seetharam K, et al. Minimally invasive coronary bypass versus percutaneous coronary intervention for isolated complex stenosis of the left anterior descending coronary artery. J Thorac Cardiovasc Surg. 2020. PMID: 32653282. doi:10.1016/j.jtcvs.2020.04.171

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。